Northway Biotech, established in 2004, is a leading biologics contract development and manufacturing organization (CDMO) with mammalian and microbial capacity available in the United States and Lithuania. We have completed 150+ projects for 90+ clients across the globe.
Both our locations provide end-end capabilities, encompassing cell line/strain development, formulation development, upstream/downstream process development, analytical development, cGMP manufacturing, fill/finish, and comprehensive quality/regulatory support. We offer both single-use and stainless-steel systems for mammalian and microbial-based process development and manufacturing.
To ensure flexibility and efficiency, we have established over 40 R&D labs and 10 cGMP manufacturing lines across our facilities. At Northway, we are fully focused on the commercial success of our clients.